NSAID/tranexamic acid - Arstat

Drug Profile

NSAID/tranexamic acid - Arstat

Alternative Names: Enhanta

Latest Information Update: 20 Jul 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator ARSTAT
  • Class Cyclohexanecarboxylic acids; Nonsteroidal anti-inflammatories; Small molecules
  • Mechanism of Action Cyclooxygenase inhibitors; Plasminogen activator inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No
  • Available For Licensing Yes

Highest Development Phases

  • Phase Unknown Dysmenorrhoea; Menorrhagia

Most Recent Events

  • 20 Jul 2016 NSAID/tranexamic acid - Arstat is available for licensing - http://arstatinc.com/ARSTAT_Combination.pdf
  • 20 Jul 2016 Investigation in Dysmenorrhoea in USA (PO)
  • 20 Jul 2016 Investigation in Menorrhagia in USA (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top